1. RETRACTED ARTICLE: Epigenetic regulation of HGF/Met receptor axis is critical for the outgrowth of bone metastasis from breast carcinoma
   Paola Bendinelli et al, 2017, Cell Death & Disease CrossRef
2. FLVCR1 Predicts Poor Prognosis and Promotes Malignant Phenotype in Esophageal Squamous Cell Carcinoma via Upregulating CSE1L
   Suna Zhou et al, 2021, Frontiers in Oncology CrossRef
3. New insights into the prognostic value of Ki-67 labeling index in patients with triple-negative breast cancer
   Shuang Hao et al, 2016, Oncotarget CrossRef
4. A Prognostic Model for Patients with Triple-Negative Breast Cancer: Importance of the Modified Nottingham Prognostic Index and Age
   Jeanny Kwon et al, 2017, Journal of Breast Cancer CrossRef
5. Emerging Biomarkers in Cutaneous Melanoma
   Anna Eisenstein et al, 2018, Molecular Diagnosis & Therapy CrossRef
6. Diagnostic and prognostic value of tissue and circulating levels of Ephrin-A2 in prostate cancer
   Shibao Li et al, 2016, Tumor Biology CrossRef
7. Regulatory and therapeutic implications of competing endogenous RNA network in breast cancer progression and metastasis: A review
   I. Saranya et al, 2024, International Journal of Biological Macromolecules CrossRef
8. HOXC-AS2 mediates the proliferation, apoptosis, and migration of non-small cell lung cancer by combining with HOXC13 gene
   Bin Liu et al, 2021, Cell Cycle CrossRef
9. Acoustic radiation force impulse elastography in evaluation of triple-negative breast cancer: A preliminary experience
   Jing Wan et al, 2018, Clinical Hemorheology and Microcirculation CrossRef
10. Ki‑67 is an independent prognostic marker for the recurrence and relapse of oral squamous cell carcinoma
    Yue Jing et al, 2018, Oncology Letters CrossRef
11. Rim sign and histogram analysis of apparent diffusion coefficient values on diffusion-weighted MRI in triple-negative breast cancer: Comparison with ER-positive subtype
    Yangsean Choi et al, 2017, PLOS ONE CrossRef
12. Identification of recurrent BRCA1 mutation and its clinical relevance in Chinese Triple‐negative breast cancer cohort
    Xiaoran Liu et al, 2017, Cancer Medicine CrossRef
13. Distinct Oncogenic Transcriptomes in Human Mammary Epithelial Cells Infected With Cytomegalovirus
    Sandy Haidar Ahmad et al, 2021, Frontiers in Immunology CrossRef
14. BRCA1 deficiency is a recurrent event in early-onset triple-negative breast cancer: a comprehensive analysis of germline mutations and somatic promoter methylation
    Rafael Canfield Brianese et al, 2018, Breast Cancer Research and Treatment CrossRef
15. Correlation between DCE‑MRI radiomics features and Ki‑67 expression in invasive breast cancer
    Ma‑Wen Juan et al, 2018, Oncology Letters CrossRef
16. Triple negative breast cancer chemosensitivity and chemoresistance: current advances in biomarkers indentification
    Fouzia Guestini et al, 2016, Expert Opinion on Therapeutic Targets CrossRef
17. Early diagnosis and clinical application of systemic lupus erythematosus based on a nomogram model
    Yalin Yang et al, 2024, Heliyon CrossRef
18. C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition
    Tae-Min Cho et al, 2019, Cancer Letters CrossRef
19. Androgen Receptor Expression in Thai Breast Cancer Patients
    Suthat Chottanapund et al, 2016, Medical Sciences CrossRef
20. Genome-wide effects of MELK-inhibitor in triple-negative breast cancer cells indicate context-dependent response with p53 as a key determinant
    Marisa Simon et al, 2017, PLOS ONE CrossRef